Landos Biopharma to Present Two Late-Breaking Presentations on Therapeutic Potential of Omilancor and PX-69 at the 2021 American Association of Immunologists (AAI) Annual Meeting
Robust preclinical data supports breadth and growth of Landos’ autoimmune-focused pipelineCompany expects to submit an IND for omilancor as a...
pcc Practice Builder™ Emerges as a Growth Engine for Medical Practices in 2026